About Sherlock Biosciences
Sherlock Biosciences is a company based in Watertown (United States) founded in 2019 by David Walt, Omar Abudayyeh, and Jonathan Gootenberg was acquired by OraSure in December 2024. It operates as a HealthTech. Sherlock Biosciences has raised $111 million across 8 funding rounds from investors including United States Department of Agriculture, Gates Foundation and OraSure Technologies. The company has 33 employees as of December 31, 2020. Sherlock Biosciences has completed 1 acquisition, including Sense Biodetection. Sherlock Biosciences offers products and services including SHERLOCK™ and INSPECTR™. Sherlock Biosciences operates in a competitive market with competitors including GRAIL, Amyris, Syngenta, AskBio and Color, among others.
- Headquarter Watertown, United States
- Employees 33 as on 31 Dec, 2020
- Founders David Walt, Omar Abudayyeh, Jonathan Gootenberg
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Orasure Technologies, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$111 M (USD)
in 8 rounds
-
Latest Funding Round
$298.95 K (USD), Grant
Aug 08, 2024
-
Investors
United States Department of Agriculture
& 10 more
-
Employee Count
33
as on Dec 31, 2020
- Investments & Acquisitions
-
Acquired by
OraSure
(Dec 19, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sherlock Biosciences
Sherlock Biosciences offers a comprehensive portfolio of products and services, including SHERLOCK™ and INSPECTR™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
CRISPR-based tool for rapid DNA/RNA detection used.
Synthetic biology platform for affordable diagnostics developed.
Unlock access to complete
Leadership Team
8 people
Product Management Team
4 people
Finance and Accounting
2 people
Legal and Compliance
1 people
Human Resources and Administration
1 people
Operations Team
1 people
Chair Team
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Sherlock Biosciences
Sherlock Biosciences has successfully raised a total of $111M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $298.95 thousand completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Grant — $298,948
-
First Round
First Round
(23 Apr 2019)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Grant - Sherlock Biosciences | Valuation |
investors |
|
| Jul, 2023 | Amount | Grant - Sherlock Biosciences | Valuation |
investors |
|
| Nov, 2022 | Amount | Grant - Sherlock Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sherlock Biosciences
Sherlock Biosciences has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include United States Department of Agriculture, Gates Foundation and OraSure Technologies. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and advisory services are provided for life sciences.
|
Founded Year | Domain | Location | |
|
Health tech startups are invested in by Illumina Ventures.
|
Founded Year | Domain | Location | |
|
Investments in healthtech startups are made by Albany Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sherlock Biosciences
Sherlock Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sense Biodetection. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of point of care molecular diagnostics solutions
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Sherlock Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sherlock Biosciences Comparisons
Competitors of Sherlock Biosciences
Sherlock Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Amyris, Syngenta, AskBio and Color, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sherlock Biosciences
Frequently Asked Questions about Sherlock Biosciences
When was Sherlock Biosciences founded?
Sherlock Biosciences was founded in 2019.
Where is Sherlock Biosciences located?
Sherlock Biosciences is headquartered in Watertown, United States.
Who is the current CEO of Sherlock Biosciences?
Bryan Dechairo is the current CEO of Sherlock Biosciences.
Is Sherlock Biosciences a funded company?
Sherlock Biosciences is a funded company, having raised a total of $111M across 8 funding rounds to date. The company's 1st funding round was a Grant of $2M, raised on Apr 23, 2019.
How many employees does Sherlock Biosciences have?
As of Dec 31, 2020, the latest employee count at Sherlock Biosciences is 33.
What does Sherlock Biosciences do?
Sherlock Biosciences, a subsidiary of OraSure Technologies, is dedicated to the development of molecular diagnostics using CRISPR and synthetic biology. The company is engaged in creating rapid, accurate, and affordable diagnostic tools through proprietary platforms like SHERLOCK and INSPECTR. Solutions are designed for point-of-need testing to democratize and decentralize healthcare. The focus is on personalizing healthcare and impacting global health by enabling accessible diagnostic answers in various settings.
Who are the top competitors of Sherlock Biosciences?
What products or services does Sherlock Biosciences offer?
Sherlock Biosciences offers SHERLOCK™ and INSPECTR™.
How many acquisitions has Sherlock Biosciences made?
Sherlock Biosciences has made 1 acquisition, including Sense Biodetection.
Who are Sherlock Biosciences's investors?
Sherlock Biosciences has 11 investors. Key investors include United States Department of Agriculture, Gates Foundation, OraSure Technologies, Novalis LifeSciences, and Illumina Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.